Literature DB >> 22492517

Relationship between neurologic deficit severity and final functional outcome shifts and strengthens during first hours after onset.

Jeffrey L Saver1, Hernan Altman.   

Abstract

BACKGROUND AND
PURPOSE: Early neurological deficit severity is the most important determinant of final functional outcome in acute ischemic stroke. However, deficit severity frequently changes during the first hours and days postonset.
METHODS: Analysis of control group patients enrolled in the 2 National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials. Neurological deficit severity was measured serially using the National Institutes of Health Stroke Scale (NIHSS) at 1 to 3 hours postonset, 3 to 5 hours, 24 hours, 7 to 10 days, and 90 days. Final global disability outcome was assessed at 90 days using the modified Rankin Scale.
RESULTS: Among the 312 patients, median neurological deficit severity on the NIHSS improved throughout the 90-day observation period, from 15 (interquartile range, 9.5-20) at 1 to 3 hours, to 12 (interquartile range, 6-19) at 24 hours, to 7 (interquartile range, 2-19) at 90 days. Between 1-to-3-hours to 24 hours, more patients spontaneously improved than worsened: 39.1% versus 17.6% (P<0.001). NIHSS scores associated with individual final modified Rankin Scale global disability ranks shifted to lower values over time; eg, patients with a final modified Rankin Scale of 2 had the following median NIHSS scores: 12 at 1 to 3 hours, 10 at 3 to 5 hours, 9 at 24 hours, and 3 at 90 days. Correlation coefficients between NIHSS and the final modified Rankin Scale increased over time, from 0.51 at 1 to 3 hours, to 0.72 at 24 hours, to 0.87 at 90 days.
CONCLUSIONS: During the first 24 hours after onset, spontaneous improvement occurs in 2 of 5 acute ischemic stroke patients. The NIHSS scores associated with individual global disability ranks decrease over time. Neurological deficit severity increasingly predicts final disability outcome, accounting for one quarter of the variance at 1 to 3 hours, one half at 24 hours, and three quarters at 90 days.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492517      PMCID: PMC3509751          DOI: 10.1161/STROKEAHA.111.636928

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program.

Authors:  Eric E Smith; Nandavar Shobha; David Dai; Daiwai M Olson; Mathew J Reeves; Jeffrey L Saver; Adrian F Hernandez; Eric D Peterson; Gregg C Fonarow; Lee H Schwamm
Journal:  Circulation       Date:  2010-09-27       Impact factor: 29.690

2.  Graphic reanalysis of the two NINDS-tPA trials confirms substantial treatment benefit.

Authors:  Jeffrey L Saver; Jeffrey Gornbein; Sidney Starkman
Journal:  Stroke       Date:  2010-09-09       Impact factor: 7.914

3.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

4.  Serial assessment of acute stroke using the NIH Stroke Scale.

Authors:  R J Wityk; M S Pessin; R F Kaplan; L R Caplan
Journal:  Stroke       Date:  1994-02       Impact factor: 7.914

5.  Neural correlates of motor recovery after stroke: a longitudinal fMRI study.

Authors:  N S Ward; M M Brown; A J Thompson; R S J Frackowiak
Journal:  Brain       Date:  2003-08-22       Impact factor: 13.501

6.  A method to determine stroke trial success using multidimensional pooled control functions.

Authors:  Pitchaiah Mandava; Thomas A Kent
Journal:  Stroke       Date:  2009-03-12       Impact factor: 7.914

7.  Spontaneous improvement after acute ischemic stroke. A pilot study.

Authors:  J Biller; B B Love; E E Marsh; M P Jones; L E Knepper; D Jiang; H P Adams; D L Gordon
Journal:  Stroke       Date:  1990-07       Impact factor: 7.914

8.  Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials.

Authors:  Inke R König; Andreas Ziegler; Erich Bluhmki; Werner Hacke; Philip M W Bath; Ralph L Sacco; Hans C Diener; Christian Weimar
Journal:  Stroke       Date:  2008-04-10       Impact factor: 7.914

  8 in total
  31 in total

1.  Prognostic Value of the 24-Hour Neurological Examination in Anterior Circulation Ischemic Stroke: A post hoc Analysis of Two Randomized Controlled Stroke Trials.

Authors:  Srikant Rangaraju; Michael Frankel; Tudor G Jovin
Journal:  Interv Neurol       Date:  2016-02-19

2.  Revisiting 'progressive stroke': incidence, predictors, pathophysiology, and management of unexplained early neurological deterioration following acute ischemic stroke.

Authors:  Pierre Seners; Jean-Claude Baron
Journal:  J Neurol       Date:  2017-04-28       Impact factor: 4.849

3.  Perfusion Changes of Unexplained Early Neurological Deterioration After Reperfusion Therapy.

Authors:  Jingjing Fu; Ying Zhou; Qingqing Li; Genlong Zhong; Sheng Zhang; Ruiting Zhang; Chang Liu; Minming Zhang; Min Lou
Journal:  Transl Stroke Res       Date:  2019-08-28       Impact factor: 6.829

4.  Neurologic Examination at 24 to 48 Hours Predicts Functional Outcomes in Basilar Artery Occlusion Stroke.

Authors:  Srikant Rangaraju; Tudor G Jovin; Michael Frankel; Wouter J Schonewille; Ale Algra; L Jaap Kappelle; Raul G Nogueira
Journal:  Stroke       Date:  2016-09-01       Impact factor: 7.914

Review 5.  Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages.

Authors:  Taimur Dad; Daniel E Weiner
Journal:  Semin Nephrol       Date:  2015-07       Impact factor: 5.299

6.  Early function decline after ischemic stroke can be predicted by a nomogram based on age, use of thrombolysis, RDW and NIHSS score at admission.

Authors:  Gianni Turcato; Gianfranco Cervellin; Manuel Cappellari; Antonio Bonora; Massimo Zannoni; Paolo Bovi; Giorgio Ricci; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2017-04       Impact factor: 2.300

7.  Overlap in the Genetic Architecture of Stroke Risk, Early Neurological Changes, and Cardiovascular Risk Factors.

Authors:  Laura Ibanez; Laura Heitsch; Umber Dube; Fabiana H G Farias; John Budde; Kristy Bergmann; Rich Davenport; Joseph Bradley; Caty Carrera; Janne Kinnunen; Hanne Sallinen; Daniel Strbian; Agnieszka Slowik; Israel Fernandez-Cadenas; Joan Montaner; Jin-Moo Lee; Carlos Cruchaga
Journal:  Stroke       Date:  2019-05-14       Impact factor: 7.914

8.  Introduction of direct oral anticoagulant within 7 days of stroke onset: a nomogram to predict the probability of 3-month modified Rankin Scale score > 2.

Authors:  Manuel Cappellari; Gianni Turcato; Stefano Forlivesi; Nicola Micheletti; Giampaolo Tomelleri; Bruno Bonetti; Giovanni Merlino; Roberto Eleopra; Monia Russo; Roberto L'Erario; Alessandro Adami; Carolina Gentile; Anna Gaudenzi; Sandro Bruno; Paolo Bovi
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

9.  Early neurological stability predicts adverse outcome after acute ischemic stroke.

Authors:  Hannah J Irvine; Thomas Wk Battey; Ann-Christin Ostwaldt; Bruce Cv Campbell; Stephen M Davis; Geoffrey A Donnan; Kevin N Sheth; W Taylor Kimberly
Journal:  Int J Stroke       Date:  2016-07-09       Impact factor: 5.266

Review 10.  Blood biomarkers for physical recovery in ischemic stroke: a systematic review.

Authors:  Yun-Ju Lai; Sandra K Hanneman; Rebecca L Casarez; Jing Wang; Louise D McCullough
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.